CN101468123A - Gel patch for treating migraine and method for preparing the same - Google Patents
Gel patch for treating migraine and method for preparing the same Download PDFInfo
- Publication number
- CN101468123A CN101468123A CNA2007100604707A CN200710060470A CN101468123A CN 101468123 A CN101468123 A CN 101468123A CN A2007100604707 A CNA2007100604707 A CN A2007100604707A CN 200710060470 A CN200710060470 A CN 200710060470A CN 101468123 A CN101468123 A CN 101468123A
- Authority
- CN
- China
- Prior art keywords
- gel
- preparation
- medicine
- adhesive
- migrainous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a gel plaster for hemicrania and its preparation mehtod thereof, composed of 2% -100% of extract of traditional Chinese medicine and 98% -0% of medicinal adjuvant, wherein the extracts of the chuanxiong rhizome, radix ligustici sinensis, cyperirhizome are fat-soluble extracts using supercritical fluid extraction method. The traditional Chinese medicine plaster is prepared by mixing the molecule gel with the hydrogel and the fat-soluble medicine enters into the skin by a fat-soluble channel, thus the production technique prevents the separation of medicine and matrix, at the same time a certain repulsion force of water-based matrix to the oil-based medicine can promote the medicine absorption and the medicine efficacy is increased.
Description
Technical field
The present invention relates to up-to-date molecular gel novel form of Percutaneously administrable preparation technical field and hydrogel dosage form, add medicinal substrate with Chinese medicine extract and treat migrainous Transdermal absorption gel adhesive and preparation method thereof.
Background technology
Transdermal drug delivery system or percutaneous absorption patch refer to stick the mode medication through skin, and medicine enters the systemic blood circulation by skin absorbs and reaches a class preparation of effective blood drug concentration, realization disease treatment or prevention.The characteristics of percutaneous absorption patch are, transdermal drug delivery system can avoid the first pass effect of liver and medicine in the gastrointestinal deactivation, the absorption of medicine is not subjected to the influence of gastrointestinal factors, reduce the individual variation of medication, keep constant effective blood drug level or physiological effect, the blood drug level peak valley phenomenon of avoiding oral administration to cause reduces toxicity.Reduce administration number of times, improve therapeutic efficacy, prolong action time, avoid multiple dose administration, make most patient be easy to accept, simultaneously easy to use, independently medication of patient also can be cancelled medication at any time.
The profit ampholytic gels is meant that hydrogel and molecular gel (cry not only organogel) be mixed and made into can dissolve fat-soluble medicine but also can dissolve the gel of water soluble drug.Hydrogel is to be solvent with water, can dissolve water soluble drug, and molecular gel is to be solvent with the organic solvent, can dissolve fat-soluble medicine.Molecular gel is that the gel factor (some micromolecule organic compound) is passed through non-covalent interaction in non-aqueous media, spontaneously assembles, assembles orderly three-dimensional fiber network structure, makes the medium gelation.Reversible characteristics processing technology that molecular gel has heat is simple, and gelinite contains a large amount of organic solvents, be fit to the storage storehouse as lipophilic medicament, but molecular gel exists cohesiveness low, and viscosity is little, with the skin poor compliance, is not suitable for making shortcomings such as patch.Hydrogel water content height is fit to the storage storehouse as hydrophilic medicament, and is strong to the skin compliance, but is subjected to the influence of self property, and colloid poor plasticity, elasticity are little.In sum, be advantage in conjunction with these two kinds of gels, adopt the profit ampholytic gels factor that two kinds of gelinites are disperseed mixing, with the molecular gel is framework material, the patch substrate that hydrogel is made as sticky stuff, both high resilience forms have good compliance with skin, can peel off repeatedly, paste again, improve the drug loading of hydrophilic medicament and hydrophobic drug simultaneously again.Two kinds of gels twine staggered uniform distribution in substrate, by non-covalent bond form combinations such as Van der Waals forces, by fully contacting with skin, the both sexes medicine continues to see through skin through passage separately, enters blood circulation, the performance drug effect.
Migraine is a kind of headache of periodical attack, and the international association of having a headache is defined as intermittent headache outbreak with migraine and with autonomic imbalance, has or absence of aura.Migraine has two major types: migraine also has other rare type with tendency (being once called as classical migraine) and Migraine without aura (being once called as common migraine).
Chinese patent CN1352980 discloses the migrainous medicine of a kind of treatment, and this compound preparation filters out blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, the Chinese medicine Rhizoma Chuanxiong of wind-expelling pain-stopping and the resolving depression of regulating the flow of vital energy, the Chinese medicine Rhizoma Cyperi of menstruction regulating and pain relieving.We have also added the ligusticum sinense volatile oil that extracts from the Rhizoma Ligustici of expelling wind and cold, removing dampness to relieve pain.The treatment migraine has better effect.
Summary of the invention
The objective of the invention is to advantage in conjunction with up-to-date molecular gel and hydrogel, can avoid the migrainous Western medicine of traditional oral medication to stimulate the shortcoming of stomach, avoid general aqueous gel poor plasticity, oil-base gel agent again shortcomings such as big, the easy pollution clothes of skin irritation.The invention provides a kind of to treatment migraine effect remarkable and side effect is little, release slowly steadily, to little Transdermal absorption gel adhesive of skin irritation and preparation method thereof.
The technical solution used in the present invention is: migrainous gel adhesive of a kind of treatment and preparation method thereof, it is made up of backing layer, adhesive-layer, protective layer, it is characterized in that the adhesive-layer in this patch mainly is made up of medicine, mixed gel and short penetrating agent.Said preparation is made up of following raw materials in weight portion: Rhizoma Chuanxiong 1-50 weight portions, Rhizoma Ligustici 1-50 weight portions, Rhizoma Cyperi 1-50 weight portions, transdermal enhancer 3-15 weight portions, mixed gel 100-500 weight portions (molecular gel: hydrogel is 1:1-10); The weight percent content of total volatile oil is 2%-30% in the gel adhesive.Transdermal penetration agent, the molecular gel that contains the oil-soluble extract and hydrogel add with order respectively in proportion, and mix homogeneously is uniformly coated on the backing layer, the compound protective layer of going up, and after the extrusion modling, sterilization, stamping-out are made product.
Described drug molecule gel can be made as follows: 1%-30% gel factor is dissolved in the mixture of specific organic solvent or organic solvent.Medicine is dissolved in the organic solvent, adds a certain amount of gel factor then and mix, promptly get molecular gel.The gel factor that is adopted is divided into two classes, the first kind is simple tertiary amine and quaternary ammonium salt thereof such as lecithin, N, N, the two octadecane amine of N-three-octadecane amine, gallbladder steroid eicosane amine, methyl, dioctadecyl dimethyl ammonium chloride and cyclodextrin derivative class as: organic molecules such as beta-schardinger dextrin-, second class are derivative of fatty acid as 12-hydroxy octadecadienoic acid and associated salts, glyceryl monostearate etc.; Organic solvent comprises alkanes, arene, dimethyl sulfoxide (DMSO), acetonitrile, 1-propanol, 1-amylalcohol, 1-capryl alcohol, 1,2-propylene glycol, glycerol, silicone oil etc.
Described medicine hydrogel can be made as follows:
The first kind, 2%-15% sodium polyacrylate, 1%-30%PVP and 1%-20%CMC-Na pressed powder mix homogeneously are scattered in 15%-60% propylene glycol, the glycerol solvent, and mix homogeneously adds 40%-80% deionized water mix homogeneously promptly.The 0%-15% additive, additive comprises: Kaolin, starch, micropowder silica gel, aluminum chloride, Alumen, sodium alginate etc.
Second class, 0.1%-10% carbomer, 1%-20% sodium polyacrylate, 15%-40% glycerol, 30%-80% propylene glycol, 3%-15% ethanol, 5%-20% additive, additive comprises: Kaolin, starch, micropowder silica gel, citric acid, citric acid, ethanol, aluminum chloride, triethanolamine, ethyl hydroxybenzoate, ammonium stearate, disodium EDTA (EDTA-2Na), sodium benzoate, parabens or the like.
The above-mentioned described first kind prescription gel factor can only cooperate with first kind gel, and the second gellike factor and the second gellike agent cooperate.
Penetrating agent of the present invention comprises dimethyl sulfoxide and analog: dimethyl sulfoxide (DMSO); Azone compounds: laurocapram Azone; Alcohol compound: ethanol, propylene glycol, glycerol or the like.Described backing layer is non-woven fabrics or polyester film, and protective layer is paper or polyester film through release treatment.
Chinese crude drug extraction process of the present invention is not limited to supercritical fluid extraction, also can be other extraction processes such as alcohol extraction organic solvent extractionprocess; Coating processes such as the also available blade coating molding of the preparation technology of patch.Gel adhesive of the present invention can be made arbitrary shape.
Process conditions:
A. extract drugs technology
(a) extraction of Rhizoma Cyperi: get a certain amount of Rhizoma Cyperi, supercritical fluid extraction, 45 ℃ of temperature, pressure 30MPa, CO
2Flow 30kgh
-1, time 2h.Emit extract, standby.
(b) extraction of Rhizoma Chuanxiong: get a certain amount of Rhizoma Chuanxiong, supercritical fluid extraction, 55 ℃ of temperature, pressure 25MPa, CO
2Flow 40kgh
-1, time 2h.Emit extract, standby.
(c) extraction of Rhizoma Ligustici: get a certain amount of Rhizoma Ligustici, supercritical fluid extraction, 50 ℃ of temperature, pressure 35MPa, CO
2Flow 25kgh
-1, time 3h.Emit extract, standby.
The preparation technology of B, patch:
(a) preparing process of profit ampholytic gels:
The first kind: get a certain amount of sodium polyacrylate, PVP and CMC-Na pressed powder and add in the agitator, heat 20-90 ℃, be scattered in propylene glycol, the glycerol solvent, mix homogeneously, add required organic solvent and the fat-soluble medicine extract mixing of molecular gel after adding the deionized water mix homogeneously, after slowly mixing after the adding mixed gel factor, progressively reduce to room temperature, form the profit ampholytic gels.
Second class: get in a certain amount of carbomer, sodium polyacrylate, glycerol, propylene glycol, ethanol, the additive adding agitator, heat 20-90 ℃, behind the mix homogeneously, add required organic solvent and the fat-soluble medicine extract mixing of molecular gel, after slowly mixing after the adding mixed gel factor, progressively reduce to room temperature, form the profit ampholytic gels.
(b) preparation technology of paster
The drug matrices that is mixed is evenly coated on the backing layer non-woven fabrics, will covers on the medicine glue-line through the polyester protecting film that release treatment is crossed, enter the roller bearing extrusion modling, THICKNESS CONTROL is below 5mm.Stamping-out, screening, quality inspection, packing are carried out by specification in the sterilization back.
The specific embodiment
Below example by the specific embodiment, foregoing of the present invention is described in further detail, embodiment only is indicative, means that never it limits the scope of the invention by any way.But under the situation that does not break away from the above-mentioned technological thought of the present invention, the various replacements of making according to ordinary skill knowledge and habitual means or the modification of change include within the scope of the invention.
Embodiment:
Transdermal enhancer azone, dimethyl sulfoxide 10kg
Molecular gel 2.5% lecithin
97.5% Semen Myristicae isopropyl ester 100kg
Hydrogel 8% sodium polyacrylate, 2% polyvinylpyrrolidone
2% sodium carboxymethyl cellulose, 20% propylene glycol
20% glycerol, 48% deionized water 400kg
Rhizoma Cyperi extract 25kg
Rhizoma Chuanxiong extract 20kg
Rhizoma Ligustici extract 20kg
Take by weighing the 32kg sodium polyacrylate, 8kg polyvinylpyrrolidone and 8kg sodium carboxymethyl cellulose pressed powder mix homogeneously, be scattered in the 80kg propylene glycol, in the 80kg glycerol solvent, mix homogeneously in agitator, add the 192L deionized water, mix homogeneously, get 97.5kg Semen Myristicae isopropyl ester and place agitator, add Rhizoma Cyperi extract 25kg, the 20kg Rhizoma Chuanxiong extract, 25kg Rhizoma Ligustici extract and 10kg azone, the mixture of dimethyl sulfoxide, 60 ℃ of heated and stirred are to complete mixing, add 2.5kg lecithin, after slowly stirring with 100 rev/mins, cooling, temperature reduce to stop to stir after the room temperature leave standstill 5h gel.The drug gel substrate that is mixed is evenly sprayed cloth on the backing layer non-woven fabrics, will cover on the medicine glue-line through the polyester protecting film that release treatment is crossed, enter the roller bearing extrusion modling, THICKNESS CONTROL is below 5mm.Stamping-out is carried out by specification in the sterilization back, makes patch, and coefficient of losses 15% is pressed Chinese Pharmacopoeia patch standard through quality inspection qualification rate 85%.The certified products packing.
Respectively to hydrogel adhesive, oil-base gel agent, molecular gel agent, four kinds of gels of ampholytic gels patch from mouldability, first viscous force, peeling force, tough elastic force, seven performance indications of compliance of skin irritation, preparation stability, patient are investigated.Every definition standard is as follows.
Mouldability: four kinds of gels of equal in quality are coated on the non-woven fabrics uniformly the overall appearance of observing colloid, loosely organized degree.
First viscous force: the assay method according to the first viscous force of patch in (2005) second appendix XJ patches of Chinese Pharmacopoeia adhesive force algoscopy is measured comparison to four kinds of gels that are coated on the non-woven fabrics.
Peeling force: the assay method according to peel strength in (2005) second appendix XJ patches of Chinese Pharmacopoeia adhesive force algoscopy is measured comparison to four kinds of gels that are coated on the non-woven fabrics.
Tough elasticity: coating on the non-woven fabrics circular glass sheet of placing identical size on four kinds of gel-type vehicles, a 20g counterweight is put by sheet central authorities, after the pressure relief, observes gel shape recovery situation and compares.
Skin irritation: observe animal intact skin single and repeatedly contact gel the local excitation reaction that is produced.(300g ± 20g), male and female half and half are divided into 8 groups, 5-6 every group to choose healthy albino guinea-pig.24h is with Cavia porcellus spinal column both sides unhairing before administration, check whether skin of unhairing has wound, apply ointment or plaster in the left and right sides of every Cavia porcellus the respectively gel of same dose is observed single-dose and is removed the situation that erythema and edema appear in skin in 1h, 24h behind the gel, 48h, the 72h.Repeatedly apply ointment or plaster more than the week, observe again a week after stopping, the redness of observed and recorded skin every day and edema situation and smear the position whether pigmentation, situation such as hemorrhage are arranged.
Stability: placed at ambient temperature 1 month, the character of observing each gel changes situation.
Patient's compliance: select some normal adults, stick four kinds of gels respectively, compare from situations such as the sensation of skin, degree easy to use.
Four kinds of various performance comparison results of gel
Annotate: +++for well; ++ in; + for poor
Claims (7)
1. treat migrainous gel adhesive and preparation method thereof; it is characterized in that: it is made up of backing layer, adhesive-layer, protective layer; adhesive-layer is mixed and made into by Chinese medicine extract and molecular gel, hydrogel, transdermal enhancer; the weight portion proportioning is: Rhizoma Chuanxiong 1-50 weight portions; Rhizoma Ligustici 1-50 weight portions; Rhizoma Cyperi 1-50 weight portions, transdermal enhancer 3-15 weight portions, mixed gel 100-500 weight portions (molecular gel: hydrogel is 1:1-10).
2. according to migrainous gel adhesive of the described treatment of claim 1 and preparation method thereof, it is characterized in that: described molecular gel is formed and percentage by weight is: the gel factor 1%-30%, solvent or their mixture 50%-90%.The gel factor comprises the tertiary amine of ad hoc structure and quaternary amines organic compound thereof such as lecithin, N, N, N-three-octadecane amine, gallbladder steroid eicosane amine, the two octadecane amine of methyl, dioctadecyl dimethyl ammonium chloride; Organic molecules such as cyclodextrin derivative class such as beta-schardinger dextrin-; Derivative of fatty acid such as 12-hydroxy octadecadienoic acid and associated salts thereof, glyceryl monostearate, glyceryl tristearate, tripalmitin etc.Solvent comprises alkanes, arene, dimethyl sulfoxide (DMSO), acetonitrile, 2-ethoxy ethanol, 1-propanol, 1-amylalcohol, 1-capryl alcohol, 1,2-propylene glycol, glycerol, silicone oil, 14/isopropyl palmitate etc.
3. according to migrainous gel adhesive of the described treatment of claim 1 and preparation method thereof, it is characterized in that: the composition of described hydrogel and percentage by weight are water-soluble base, water-insoluble substrate or their mixture 5%-30%, solvent 50%-90%, additive 1%-10%.Water-soluble base and non-aqueous substrate comprise polypropylene acid, sodium polyacrylate, carbomer resin, polyvinylpyrrolidone, sodium carboxymethyl cellulose, methylcellulose, polyvinyl alcohol and/or their mixture of various models; Additive comprises Kaolin, starch, micropowder silica gel, aluminum chloride, Alumen, sodium alginate etc.; Solvent comprises deionized water, propylene glycol, glycerol, ethanol and/or their mixture.
4. according to migrainous gel adhesive of the described treatment of claim 1 and preparation method thereof, it is characterized in that: described penetrating agent comprises dimethyl sulfoxide and analog, azone class, alcohol compound, volatile oil and/or their mixture.
5. according to migrainous gel adhesive of the described treatment of claim 1 and preparation method thereof, it is characterized in that: described backing layer is non-woven fabrics or polyester film, and protective layer is paper or polyester film through release treatment.
6. according to migrainous gel adhesive of the described treatment of claim 1 and preparation method thereof, it is characterized in that: described preparation process comprises:
1) pressed powder of water intaking gel water-soluble base, non-aqueous substrate or their mixture places agitator, adds alcohols solvent, additive, deionized water, mix homogeneously.Solvent and the fat-soluble medicine extract of getting molecular gel place agitator, add the gel factor, and 30 ℃ of-90 ℃ of heated and stirred are progressively reduced to room temperature and formed gel to mix homogeneously, and are standby.
2) drug matrices that will be mixed is uniformly coated on the backing layer non-woven fabrics, will cover on the medicine glue-line through the polyester protecting film that release treatment is crossed.Stamping-out, screening, quality inspection, packing are carried out by specification in the sterilization back.
7. according to migrainous gel adhesive of the described treatment of claim 1 and preparation method thereof, it is characterized in that: preparation technology is spreading formation process, extrusion modling or spray mo(u)lding technology.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100604707A CN101468123A (en) | 2007-12-28 | 2007-12-28 | Gel patch for treating migraine and method for preparing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100604707A CN101468123A (en) | 2007-12-28 | 2007-12-28 | Gel patch for treating migraine and method for preparing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101468123A true CN101468123A (en) | 2009-07-01 |
Family
ID=40826085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100604707A Pending CN101468123A (en) | 2007-12-28 | 2007-12-28 | Gel patch for treating migraine and method for preparing the same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101468123A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114712334A (en) * | 2022-04-08 | 2022-07-08 | 季华实验室 | A gel patch for treating traumatic injury, and its preparation method |
-
2007
- 2007-12-28 CN CNA2007100604707A patent/CN101468123A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114712334A (en) * | 2022-04-08 | 2022-07-08 | 季华实验室 | A gel patch for treating traumatic injury, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101468138A (en) | Gel patch for treating insomnia and method for preparing the same | |
| EP1033978B1 (en) | Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof | |
| JP5694665B2 (en) | Topical preparation and its usage | |
| EP1893176B1 (en) | Production of solid solutions based on poorly-soluble active substances by a short-term heating and rapid drying | |
| CN102939075A (en) | Transdermal absorption promoter, and external skin formulation thereof | |
| CN102630160A (en) | Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system | |
| CN101947322B (en) | Gel patch matrix and preparation method and application thereof | |
| CN101468187A (en) | Gel patch for treating motion sickness and preparation method thereof | |
| KR20070121666A (en) | Device for delivery of trpv1 agonists | |
| CN100544730C (en) | Magnesium isoglycyrrhetate external preparation and its production and application | |
| CN101342174B (en) | Phthiobuzonum/diclothane compound topical formulation | |
| CN1989956B (en) | Adapalene gel composition and its preparation | |
| CN102657602B (en) | 3,5-dyhydroxyl-4-isopropyl diphenylethene chitosan gel and preparation method thereof | |
| CN102379862A (en) | Spirosal-containing hydrophilic cataplasm | |
| CN1806823B (en) | Externally applied wind-expelling Chinese medicinal composition plaster | |
| CN101468074A (en) | Antalgic gel patch and preparation method thereof | |
| CN101099730A (en) | Oral solid preparation containing ambroxol hydrochloride and guaifenesin active components | |
| CN101468177A (en) | Gel patch for treating scapulohumeral periarthritis and preparation method thereof | |
| CN101468123A (en) | Gel patch for treating migraine and method for preparing the same | |
| CN101422427B (en) | Magnesium isoglycyrrhizinate cream and preparation method and use thereof | |
| CN101468059A (en) | Gel patch for treating myopia and preparation method thereof | |
| CN101468140A (en) | Gel patch for treating cardiopalmus and method for preparing the same | |
| CN105287667A (en) | Traditional Chinese medicine liquid patch for treating arthritis and rheumatism | |
| CN101468082A (en) | Gel patch for treating facial paralysis and preparation method thereof | |
| CN101468088A (en) | Gel patch for resisting depression and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090701 |